Correlation between body mass index and serum anti-Mullerian hormone level in subfertile women at BIRDEM General Hospital, Dhaka
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253878Keywords:
Anti-Müllerian hormone, Body mass index, Obesity, Ovarian reserve, Reproductive health, SubfertilityAbstract
Background: Anti-Mullerian hormone (AMH) is a crucial marker for ovarian reserve, reflecting ovarian function due to its secretion by antral follicles. Obesity can adversely affect fertility, potentially altering AMH production. The aim of this study was to assess the correlation between body mass index (BMI) and serum anti-Mullerian hormone (AMH) level in subfertile women.
Methods: This cross-sectional analytical study was carried out in the department of obstetrics and gynecology, BIRDEM General Hospital, Dhaka, over a period of 18 months from January 2023 to June 2024.
Results: Between BMI≥25 kg/m2 and <25 kg/m2 groups there were no significant differences in age distribution (mean ages: 30.5 versus 30.4 years, p=0.912). There were no significant differences in education, occupation, or income distribution between two groups. Menstrual regularity and flow differed significantly, with more irregular cycles and heavier flow in the BMI≥25 group (p<0.0001 and p=0.049, respectively). Serum AMH levels were significantly lower in the BMI≥25 group (1.7 versus 3.1, p<0.0001). A negative correlation was found between serum AMH levels and BMI, indicated that serum AMH level decreases with increasing BMI (p<0.0001). Age and BMI were inversely significantly associated with serum AMH level adjusted for each other.
Conclusions: Higher BMI was associated with lower serum AMH levels in subfertile women, suggesting that elevated BMI may negatively impact serum AMH level which is a potential marker of ovarian reserve.
Metrics
References
Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95(1):170-5. DOI: https://doi.org/10.1016/j.fertnstert.2010.04.006
Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception. 2010;81(3):245-8. DOI: https://doi.org/10.1016/j.contraception.2009.10.004
Cui L, Qin Y, Gao X, Lu J, Geng L, Ding L, et al. Anti Müllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to post menopause. Fertil Steril. 2016;105(2):481-5. DOI: https://doi.org/10.1016/j.fertnstert.2015.10.017
Shrikhande SV, Shinde RS, Chaudhari VA, Kurunkar SR, Desouza AL, Agarwal V, et al. Twelve hundred consecutive pancreato-duodenectomies from single centre: impact of centre of excellence on pancreatic cancer surgery across India. World J Surg. 2020;44(8):2784-93. DOI: https://doi.org/10.1007/s00268-019-05235-0
Olszanecka‐Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P. Circulating anti‐Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Clin Endocrinol. 2015;83(1):98-104. DOI: https://doi.org/10.1111/cen.12687
Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss III JF. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2007;87(1):101-6. DOI: https://doi.org/10.1016/j.fertnstert.2006.05.074
Ahmed T, Hossain M, Sanin KI. Global burden of maternal and child undernutrition and micronutrient deficiencies. Ann Nutr Metab. 2013;61(1):8-17. DOI: https://doi.org/10.1159/000345165
NIPORT. Bangladesh Demographic and Health Survey BDHS 2017-18: Key Indicators; National Institute of Population Research and Training (NIPORT): Dhaka, Bangladesh. 2019.
National Institute of Population Research, Training (Bangladesh); Mitra and Associates (Firm); Macro International. Bangladesh Demographic and Health Survey 2014; National Institute of Population Research and Training (NIPORT): Dhaka, Bangladesh. 2016.
Nelson SM, Telfer EE, Anderson RA. The ageing ovary and uterus: new biological insights. Hum Reprod Update. 2013;19(1):67-83. DOI: https://doi.org/10.1093/humupd/dms043
Itriyeva K. The effects of obesity on the menstrual cycle. Curr Problems Pediatr Adolesc Health Care. 2022;52(8):101241. DOI: https://doi.org/10.1016/j.cppeds.2022.101241
Oldfield AL, Kazemi M, Lujan ME. Impact of obesity on anti-mullerian hormone (AMH) levels in women of reproductive age. J Clin Med. 2021;10(14):3192. DOI: https://doi.org/10.3390/jcm10143192
Moy V, Jindal S, Lieman H, Buyuk E. Obesity adversely affects serum anti-Müllerian hormone (AMH) levels in Caucasian women. J Assist Reprod Genet. 2015;32(9):1305-11. DOI: https://doi.org/10.1007/s10815-015-0538-7
Gupta M, Yadav R, Mahey R, Agrawal A, Upadhyay A, Malhotra N, et al. Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes- a cross-sectional study. Gynecol Endocrinol. 2019;35(11):970-3. DOI: https://doi.org/10.1080/09513590.2019.1613640
Saran S, Roy H, Singh S. Association of BMI and AMH in infertile women with and without polycystic ovarian disease. N Indian J OBGYN. 2024;11(1):15-9. DOI: https://doi.org/10.21276/obgyn.20252024.11.1.04
Albu D, Albu A. The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients. Endocrine. 2019;63(1):157-63. DOI: https://doi.org/10.1007/s12020-018-1756-4
Bernardi LA, Carnethon MR, de Chavez PJ, Ikhena DE, Neff LM, Baird DD, et al. Relationship between obesity and anti‐Müllerian hormone in reproductive‐aged African American women. Obesity. 2017;25(1):229-35. DOI: https://doi.org/10.1002/oby.21681
Kloos J, Coyne K, Weinerman R. The relationship between anti‐Müllerian hormone, body mass index and weight loss: A review of the literature. Clin Obes. 2022;12(6):e12559. DOI: https://doi.org/10.1111/cob.12559
Downloads
Published
How to Cite
Issue
Section
